To date, the US government has agreed to purchase 200m doses of the Moderna COVID-19 Vaccine.
This new purchase would bring the US government's confirmed order commitment to 300 m doses.
Moderna will continue to leverage the company's US-based manufacturing infrastructure to supply the Moderna COVID-19 Vaccine to the US government.
The Moderna COVID-19 Vaccine received Emergency Use Authorization from the US Food and Drug Administration on December 18, 2020 and Moderna began supplying to the government shortly thereafter.
The Moderna COVID-19 Vaccine has been authorized for emergency use by the US Food and Drug Administration for active immunization to prevent coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in individuals 18 years of age and older.
Xencor Teams with UCLA to Discover and Develop Novel XmAb Therapeutics
US FDA approves Gannex's ASC41 New Drug Application and initiation of global development
Non-Invasive Vagus Nerve Stimulation Enters New Stage of COVID-19 Research
Locate Bio wins FDA breakthrough device designation for the regenerative product Chondro3
Bausch + Lomb announces Alaway(R) Preservative Free antihistamine eye drops US launch
Philippines' health ministry to probe illegal use of unauthorised COVID-19 vaccines